| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 02/18/2010 | WO2010018352A1 Heterocyclic compounds used in the treatment of diseases where enhanced m3 receptor activation is implicated |
| 02/18/2010 | WO2009013360A9 Novel fluorescent derivatives of polyamine, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumours |
| 02/18/2010 | US20100041722 Organic compounds |
| 02/18/2010 | US20100041721 Selective androgen receptor modulators |
| 02/18/2010 | CA2733523A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a .beta.2-adrenoceptor agonist |
| 02/18/2010 | CA2733447A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient |
| 02/18/2010 | CA2733190A1 Oxadiazole-2-oxides as antischistosomal agents |
| 02/17/2010 | EP2153832A2 Heterocyclic aspartyl protease inhibitors |
| 02/17/2010 | EP2152677A1 Acetamide derivatives as potassium channel modulators |
| 02/17/2010 | CN101648924A Hydroxamic acid compound used as histone deacetylase inhibitor and application thereof |
| 02/17/2010 | CN101648923A Hydroxamic acid compound used as histone deacetylase inhibitor and application thereof |
| 02/17/2010 | CN101648922A Benzamide histone deacetylase inhibitor and application thereof |
| 02/17/2010 | CN101648921A Benzamide compound used as histone deacetylase inhibitor and application thereof |
| 02/17/2010 | CN101648920A Trifluoromethyl ketone compound used as histone deacetylase inhibitor and application thereof |
| 02/16/2010 | US7662971 enzyme inhibitor for treating sleep disorders |
| 02/16/2010 | US7662849 N-cyanomethyl-2R-[(benzenesulfonyliminomethyl)amino]-3-(2-difluoromethoxyphenylmethanesulfonyl)-propionamide; treating autoimmune disorders |
| 02/16/2010 | US7662771 Drug delivery; controlled/sustained release |
| 02/16/2010 | CA2442882C Sulphones which modulate the action of gamma-secretase |
| 02/16/2010 | CA2402436C Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 02/11/2010 | US20100035943 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 02/10/2010 | EP2150532A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/10/2010 | CN101643456A Synthesis method of symmetric 1, 3, 4-oxadiazole |
| 02/10/2010 | CN100588650C Non-nucleoside reverse transcriptase inhibitors I for treating HIV mediated diseases |
| 02/09/2010 | US7659294 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists |
| 02/09/2010 | US7659026 membrane electrodes; electrocatalysts; fuel cells |
| 02/09/2010 | CA2274201C Di-or triaza-spiro[4,5]decane derivatives |
| 02/04/2010 | WO2010012442A2 Insecticidal benzenedicarboxamide derivative |
| 02/04/2010 | WO2009129267A3 Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| 02/04/2010 | US20100029952 Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems |
| 02/04/2010 | US20100029727 1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors |
| 02/04/2010 | US20100029685 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 02/04/2010 | US20100029627 Mtki quinazoline derivatives |
| 02/03/2010 | CN101638394A 6-nitro anti-caking agent and use method thereof |
| 02/03/2010 | CN101638393A Preparation method of 1-type receptor antagonist of novel hypertension II and application for lowering blood pressure, resisting tumors, and like |
| 02/02/2010 | US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases |
| 02/02/2010 | CA2358581C Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 01/28/2010 | WO2010009508A1 Antiparasitic compounds |
| 01/28/2010 | WO2009140089A3 Sulfone compounds which modulate the cb2 receptor |
| 01/28/2010 | US20100022604 Prophylactic or therapeutic agent for alopecia |
| 01/28/2010 | US20100022597 2-adamantyl-butyramide derivatives as selective 11beta-hsd1 inhibitors |
| 01/28/2010 | US20100019169 Remote laser interrogation of threat clouds and surfaces |
| 01/26/2010 | US7652044 P-38 inhibitors |
| 01/21/2010 | US20100016383 4-(3,3-dihalo-allyloxy)phenol derivatives having pesticidal properties |
| 01/21/2010 | US20100015178 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/21/2010 | CA2729212A1 Compounds and methods for modulating g protein-coupled receptors |
| 01/14/2010 | WO2010005958A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | WO2009137251A3 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings |
| 01/14/2010 | US20100010053 3-[7-(5-{3-Chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-yl]propanoic acid; multiple sclerosis, autoimmune diseases, chronic inflammatory disorders, asthma, inflammatory neuropathies, arthritis, transplantation, Crohn's disease, ulcerative colitis, lupus erythematosis, psoriasis |
| 01/14/2010 | US20100010001 Novel modulators of sphingosine phosphate receptors |
| 01/14/2010 | US20100008857 Novel hexatriene-beta-carbonyl compound |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/13/2010 | EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 01/12/2010 | US7645882 Renal protective agents which inhibit vitamin B6 deficiency disease as side effect; inhibiting advanced glycosylation endproducts |
| 01/12/2010 | US7645764 Kinase inhibitors and methods for using the same |
| 01/07/2010 | WO2010000372A2 New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 01/07/2010 | WO2010000019A1 Pain-relieving compositions of furoxan no donors and uses thereof |
| 01/07/2010 | WO2009117421A3 Heterocyclic modulators of gpr119 for treatment of disease |
| 01/07/2010 | US20100004298 P-38 inhibitors |
| 01/07/2010 | CA2761288A1 Pain-relieving compositions of furoxan no donors and uses thereof |
| 01/07/2010 | CA2726999A1 New drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 01/06/2010 | CN101619045A Double-nuclear ring metal platinum complex near-infrared light-emitting material and application thereof |
| 01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 12/31/2009 | US20090326017 Pain-relieving compositions and uses therefor |
| 12/31/2009 | US20090326012 Malononitrile Compounds |
| 12/31/2009 | US20090325924 GPCR Agonists |
| 12/29/2009 | US7638632 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties |
| 12/29/2009 | US7638539 5-(4-{2-[5-methyl-2-(4-trifluoromethyl-phenyl)-thiazol -4-yl]-ethoxy}-phenyl)-3H-[1,3,4] oxadiazol-2-one; treatment of demyelinating diseases and disorders of fatty acid metabolism and glucose utilization such as multiple scleroses |
| 12/29/2009 | US7638514 Agriculture |
| 12/24/2009 | US20090318481 Potentiators Of Glutamate Receptors |
| 12/23/2009 | EP1523475B1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 12/23/2009 | CN101611019A Macrocyclic factor VIIa inhibitors useful as anticoagulants |
| 12/23/2009 | CN100572368C Method for producing molsidomine |
| 12/22/2009 | CA2538095C Selective androgen receptor modulators and methods of use thereof |
| 12/17/2009 | US20090312365 Certain Chemical Entities, Compositions, and Methods |
| 12/15/2009 | US7632852 (1,5-diphenyl-1H-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics |
| 12/15/2009 | US7632851 5-(2-Fluoro-ethylamino)-thiazol-2-yl-benzofurazan or 2,1,3-benzothiadiazole; fluorine radioactive or not; intensely and selectively stain amyloid deposits and vascular deposits of brain tissue; drug targets; diagnosis and treatment of Alzheimer's disease; fluorescent microscopy; tomography |
| 12/10/2009 | WO2009148452A1 Novel 1,2,4 oxadiazole compounds and methods of use thereof |
| 12/10/2009 | WO2009101082A9 Substituted sulfonic acid amide compounds |
| 12/10/2009 | US20090306127 Certain Chemical Entities, Compositions and Methods |
| 12/10/2009 | US20090306016 Fatty acid amide hydrolase inhibitors |
| 12/10/2009 | CA2725573A1 Novel 1,2,4 oxadiazole compounds and methods of use thereof |
| 12/09/2009 | EP2130824A1 Composition for treating infectious diseases caused by helicobacter |
| 12/09/2009 | EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 12/09/2009 | CN100567264C Dendritic molecule and dendritic macromolecule, method of producing the same, and method of producing thioacetal compound |
| 12/08/2009 | US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 12/03/2009 | WO2009146343A1 Novel substituted pyrazoles, 1,2,4-oxadiazoles, and 1,3,4-oxadiazoles |
| 12/03/2009 | WO2009071519A9 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 12/03/2009 | US20090299072 Tetrasubstituted Benzenes |
| 12/03/2009 | US20090298894 Amino acid compounds |
| 12/03/2009 | CA2725897A1 Novel substituted pyrazoles, 1,2,4-oxadiazoles, and 1,3,4-oxadiazoles |
| 12/02/2009 | EP2128124A1 Novel hexatriene- -carbonyl compound |
| 12/02/2009 | CN100564366C Derivatives of 1,3-diones having a herbicidal activity |
| 11/26/2009 | US20090291967 Small molecule modulators of cell adhesion |
| 11/26/2009 | US20090291965 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs |
| 11/25/2009 | EP2120575A1 Sphingosine-1 -phosphate receptor agonist and antagonist compounds |
| 11/24/2009 | US7622475 3-{[(4-pyrazol-1-yl-benzyl)-(pyridine-3-sulfonyl)-amino]methyl}phenoxy)-acetic acid isopropyl ester; for reducing intraocular pressure in treating glaucoma, in a mammal |
| 11/24/2009 | US7622464 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists |
| 11/24/2009 | CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |